General Information of the Compound
| Compound ID |
CP0537889
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(S)-3-((3S,4R)-1-((S)-4-methyl-1-oxo-1-(4-(2-(piperidin-1-yl)ethyl)piperidin-1-yl)pentan-2-yl)-2-oxo-4-((E)-styryl)azetidin-3-yl)-4-phenyloxazolidin-2-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C38H50N4O4
|
||||||||||||||||||
| Molecular Weight |
626.842
|
||||||||||||||||||
| Canonical SMILES |
CC(C)C[C@H](N1[C@H](\C=C\c2ccccc2)[C@H](N2[C@H](COC2=O)c2ccccc2)C1=O)C(=O)N1CCC(CCN2CCCCC2)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C38H50N4O4/c1-28(2)26-33(36(43)40-24-19-30(20-25-40)18-23-39-21-10-5-11-22-39)41-32(17-16-29-12-6-3-7-13-29)35(37(41)44)42-34(27-46-38(42)45)31-14-8-4-9-15-31/h3-4,6-9,12-17,28,30,32-35H,5,10-11,18-27H2,1-2H3/b17-16+/t32-,33+,34-,35+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
HDUUEXOHKMSPLZ-UROXIYJWSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound